Reimbursement
The PBM says the payment model more closely aligns with the costs pharmacies often face due to "manufacturer pricing actions."
The layoffs affect Johns Hopkins University and the nonprofit Jhpiego, which works closely with USAID.
Denials are the bane of patients and providers, but without them, healthcare costs would rise, says Christine Stetler, a registered nurse and AVP of Solution Engineering at MedeAnalytics.
More practices will close and Medicare patients will pay the price, says AMA President Dr. Bruce A. Scott.
Providers have partially offset a lower patient collection rate by improving POS collections and collection on bad debt.
Letter to CEO Andrew Witty follows report of DOJ launching investigation into the company's billing methods.
The FTC maintains that PBMs systematically prefer high list price insulin products with high rebates and fees over low list products.
Sequestration and bad debt reimbursement continue to place added pressure on revenues.
Challenges include technology gaps, provider shortages and reliance on data, the paper finds.
A 2.8% payment cut went into effect on January 1 after a spending bill stripped a provision to prevent the decrease.